Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Loxoprofen Sodium Sustained Release Pellets

A technology of loxoprofen sodium and sustained-release pellets, applied in the pharmaceutical field, can solve problems such as poor ease of use, and achieve the effects of reducing irritation, good sustained-release drug characteristics, and improving compliance

Active Publication Date: 2021-05-14
CHINA PHARM UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Loxoprofen sodium includes loxoprofen sodium anhydrate, monohydrate or dihydrate, among which loxoprofen sodium dihydrate is recorded in the Japanese Pharmacopoeia Prescription and Chinese Ministry of Standards, which is a water-soluble drug At present, the oral dosage form of this drug that has been listed in the domestic and foreign markets is mainly loxoprofen sodium tablet, and the dosage is 180mg per day, which is taken in three times, and the convenience of use is poor.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Loxoprofen Sodium Sustained Release Pellets
  • Loxoprofen Sodium Sustained Release Pellets
  • Loxoprofen Sodium Sustained Release Pellets

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Embodiment 1 loxoprofen sodium sustained-release pellet capsule (2000)

[0027] prescription:

[0028] 1) Drug-loaded pill core

[0029]

[0030] 2) Isolation layer coating solution

[0031]

[0032] 3) Sustained release layer coating solution

[0033] Surelease Aqueous Dispersion 180g

[0034] Distilled water 120g

[0035] Preparation Process:

[0036] 1) Preparing drug-loaded pill cores: Pass loxoprofen sodium, starch, and microcrystalline cellulose through an 80-mesh sieve respectively, mix evenly according to the prescription ratio, add 50% ethanol, prepare soft materials, and pass through the sieve plate of the extruder Extrude the strips, put the strips into a spheronizer, and spheronize to obtain round particles. After drying at 50°C for 12 hours, sieve 0.6-1.25mm pellets to obtain the core of the pellets containing The appearance of the pill core is smooth, round and hard, suitable for coating.

[0037]2) Prepare the coating solution for the isolati...

Embodiment 2

[0041] Embodiment 2 loxoprofen sodium sustained-release pellet capsules (2000)

[0042] prescription:

[0043] 1) drug-loaded pill core is the same as embodiment 1

[0044] 2) Isolation layer coating solution

[0045]

[0046] 3) Sustained release layer coating solution

[0047] Surelease Aqueous Dispersion 240

[0048] Distilled water 160g

[0049] Preparation process: with embodiment 1.

Embodiment 3

[0050] Embodiment 3 loxoprofen sodium sustained-release pellet capsules (2000)

[0051] prescription:

[0052] 1) drug-loaded pill core is the same as embodiment 1

[0053] 2) Isolation layer coating solution

[0054]

[0055] 3) Sustained release layer coating solution

[0056] Surelease Aqueous Dispersion 270g

[0057] Distilled water 180g

[0058] Preparation process: with embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention provides a loxoprofen sodium sustained-release pellet, which consists of a drug-loaded pellet core, an isolation layer wrapped on the drug-loaded pellet core, and a sustained-release layer wrapped on the isolation layer. The weight ratio of the drug-loaded pellet core, the isolation layer and the slow-release layer is 80:1-15:2-20. The loxoprofen sodium sustained-release pellet preparation of the present invention exhibits good release characteristics in vitro, can reduce the number of administrations, improve medication compliance of patients, further stabilize blood drug concentration, and reduce gastrointestinal toxic and side effects of drugs. The invention also discloses a preparation method of the loxoprofen sodium sustained-release pellets. The method has simple process and is easy for industrial production.

Description

technical field [0001] The invention belongs to the field of pharmacy, and relates to loxoprofen sodium sustained-release pellets and a preparation method thereof. Background technique [0002] Loxoprofen Sodium (Loxoprofen Sodium) is the first propionic acid precursor non-steroidal anti-inflammatory drug (NSAIDs), which was first developed by Sankyo Co., Ltd. in Japan. It was launched in Japan in July 1986 under the trade name Le loose. After oral administration, the drug is metabolized into a trans-OH active drug in the body, inhibiting the biosynthesis of prostaglandins, that is, by binding to cyclooxygenase, covering the active center of the enzyme, thereby blocking the enzyme from catalyzing the conversion of arachidonic acid into PG Metabolism, exert analgesic, anti-inflammatory and antipyretic effects. As a new type of NSAIDs, loxoprofen sodium is different from other drugs in that it is a prodrug, which has no activity itself, and becomes active only after being ra...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/16A61K31/216A61K47/38A61P29/00A61P19/02A61P11/00
CPCA61K9/5073A61K31/216A61K47/38
Inventor 栾立标万东伟
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com